Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance

Alnylam Pharmaceuticals, Inc.Trade
Roundhill S&P 500 0DTE Covered Call Strategy ETFTrade

Price performance (Past 24H)

Key statistics

Alnylam Pharmaceuticals, Inc. vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $220.35 (market cap $29.60B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $39.43. The key difference: Roundhill S&P 500 0DTE Covered Call Strategy ETF is trading nearer its 52-week high, Alnylam Pharmaceuticals, Inc. nearer its low. Which is the better fit depends on your goals.

ALNYXDTE
Market Cap
$29.60B
Sector
HealthIncome / Options Overlay
52-Week High
$491.22$44.76
52-Week Low
$205.48$36.00
Enterprise Value
$27.56B

Returns comparison

Trailing returns across standard periods

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.

Read more on ALNY

About Roundhill S&P 500 0DTE Covered Call Strategy ETF

XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.

Read more on XDTE